FINWIRES · TerminalLIVE
FINWIRES

Astellas Pharma's Profit Soars 107% in Fiscal Q1

By

Astellas Pharma's (TYO:4503) profit attributable to owners of the parent more than doubled to 141.8 billion yen in the first quarter of fiscal 2026 from 68.4 billion yen a year earlier.

The pharmaceutical company's earnings per share increased to 78.96 yen from 38.11 yen in the year-ago quarter, according to a Tokyo Stock Exchange filing on Wednesday.

Revenue rose 27% to 640.9 billion yen in the three months ended June 30, from 505.8 billion yen a year earlier.

Operating profit climbed 95% to 184.5 billion yen, while profit before tax more than doubled to 186.5 billion yen.

Astellas maintained its full-year forecast, expecting attributable profit of 300 billion yen, basic earnings per share of 167.46 yen, and revenue of 2.220 trillion yen for fiscal 2026.

The company also kept its annual dividend forecast unchanged at 80 yen per share, comprising an interim dividend of 40 yen and a year-end dividend of 40 yen.

Related Articles

Asia

India's Market Regulator Eyes Depository Receipt Framework for REITs, Public InvITs

India's market regulator has proposed allowing real estate investment trusts (REITs) and publicly listed infrastructure investment trusts (InvITs) to issue depository receipts, according to a consultation paper published on Tuesday.The Securities and Exchange Board of India (SEBI) is proposing an enabling framework for the issuance of depository receipts backed by units of REITs and publicly listed InvITs.The regulator said the instruments would allow foreign investors to trade the securities in foreign currency on permitted international exchanges.SEBI proposed amending the REIT and InvIT regulations to permit such issuances and plans to introduce a detailed framework through a separate circular.Public comments on the consultation paper are invited until Aug. 25.

^BSENifty 50
Asia

Sharetronic Data Technology Adds 150 Million Yuan in Related Party Deals

Sharetronic Data Technology (SHE:300857) said its board approved 150 million yuan in new 2026 related-party transactions with Cheng Uei Precision for Internet of Things smart terminal product sales.This raised the annual total to 350 million yuan, according to a Wednesday filing with the Shenzhen bourse.Shares of the wireless telecommunication equipment manufacturer rose 6% in recent trade.

SHE:300857
Asia

Helens International Forecasts Lower Net Profit in H1

Helens International (SGX:HLS, HKG:9869) expects to book a net profit of up to 16 million yuan, compared with an adjusted net profit of 50.3 million yuan a year earlier.Meanwhile, the company expects a revenue of up to 260 million yuan in the first half of the year, compared to 291.2 million yuan a year earlier, according to a Tuesday filing with the Singapore Exchange.The decrease in revenue is mainly due to a decline in the number of self-operated bars during the period.

HKG:9869SGX:HLS